Myriad Genetics Inc (MYGN)

EBITDA

-$26.00M

Quarterly · Period ending: · USD

MYGN logo

MYGN EBITDA

Latest reported-$26.00M
MYGN Quarterly EBITDA ($1.00M → -$26.00M)
High-resolution chart · PNG

MYGN ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-2,461,480
-2,298,718
-2,305,596
-2,342,147
-2,600,393
-2,243,000
-1,600,000
-1,800,000
-2,300,000
-1,937,885
-2,600,000
-2,600,000
-2,900,000
-2,700,000
-2,300,000
-1,900,000
200,000
-3,300,000
-3,700,000
-3,200,000
-2,500,000
-2,300,000
-1,600,000
1,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.